和厚朴酚通过Wnt/β-连环蛋白通路抗动脉粥样硬化

The effect of honokiol on the forming process of atherosclerosis by regulating Wnt/β-catenin signaling pathway

  • 摘要: 目的 体内外观察和厚朴酚(HNK)对动脉粥样硬化(AS)模型Wnt/β-连环蛋白(β-catenin)信号通路及动脉硬化的影响;探讨和厚朴酚调控Wnt/β-catenin信号通路对AS形成过程影响的可能机制。方法 动物实验:8只SD大鼠作为正常对照组,24只高脂喂养SD大鼠随机分为AS组(高脂喂养+维生素D2注射建立AS模型),AS+HNK组建立模型后HNK腹腔注射5 mg/(kg·d),2次/d,连续8周和AS+HNK-PNU组AS+HNK组的基础上加用Wnt/β-catenin拮抗剂PNU-74654 100 mg/(kg·d),连续8周,每组8只。检测各组血脂水平,HE染色图像分析测定胸主动脉中膜面积及血管壁厚度,免疫印迹法检测大鼠胸主动脉组织Wnt/β-catenin的蛋白表达。细胞实验:培养人脐静脉内皮细胞(HUVEC)及人主动脉平滑肌细胞(HA-VSMC)分为对照组、AS模型组使用20 mg/L氧化型低密度脂蛋白(ox-LDL)干预48 h诱导建立细胞AS模型,AS+HNK组(AS+HNK 32μmol/L干预48 h)、AS+HNK-PNU组(AS+HNK 32μmol/L+PNU-74654 50μmol/L干预48 h);分别采用实时荧光定量聚合酶链反应(RT-PCR)法和Western blot法检测细胞Wnt3a和β-catenin mRNA及蛋白质表达。采用Transwell小室实验检测HA-VSMC迁移能力。结果 动物实验:与对照组相比,AS组血清三酰甘油、总胆固醇、低密度脂蛋白胆固醇(LDL-C)水平升高(均P<0.05),与AS组比较,AS+HNK组和AS+HNK-PNU组血脂水平降低(P<0.05)。与对照组比较,AS组大鼠胸主动脉中膜面积及血管壁厚度增加(均P<0.01);胸主动脉组织Wnt/β-catenin蛋白表达水平增加(P<0.05);和厚朴酚可降低AS模型大鼠胸主动脉中膜面积及血管壁厚度和Wnt/β-catenin蛋白表达水平(P<0.05),联合使用PNU-74654此效应下降。细胞实验:两种细胞株模型组Wnt3a及β-catenin mRNA和蛋白表达水平高于对照组;AS+HNK组的Wnt3a、β-catenin蛋白表达与mRNA相对表达量低于AS+HNK-PNU组及AS组(均P<0.05)。AS组HA-VSMC迁移能力高于对照组,AS+HNK组与AS+HNK-PNU组HA-VSMC迁移能力低于AS组(P<0.05)。结论 和厚朴酚可下调AS模型Wnt、β-catenin表达,抑制平滑肌细胞迁移,降低主动脉中膜面积和血管壁厚度;和厚朴酚改善AS的作用可能与Wnt/β-catenin信号通路有关。

     

    Abstract: Objective To explore the effects and the possible mechanisms of honokiol(HNK) on Wnt and β-catenin signaling pathway and arteriosclerosis in both vitro and vivo arteriosclerosis model. Methods In animal experiments, eight Sprague Dawley(SD) rats were used as control group, and twenty-four high-fat-chow-fed SD rats(to establish atherosclerosis rats model) were randomly divided into 3 groups: AS group(atherosclerosis model induced by high fat diet and vitamin D2 injected), AS+HNK group intervention with honokiol 5 mg/(kg·d) for eight weeks and AS+HNK-PNU group intervention with honokiol 5 mg/(kg·d) plus PNU-74654 100 mg/(kg·d) for eight weeks. Blood lipid levels were detected. Media cross-sectional area and wall thickness of thoracic aorta were measured by HE staining. Wnt and β-catenin protein levels were detected by Western blot. For in vitro experiments, human umbilical vein endothelial cells(HUVEC) and human aortic vascular smooth muscle cells(HA-VSMC) were cultured, and both were divided into four groups: normal control group, AS group induced by 20 mg/L oxidized low density lipoprotein(ox-LDL) for 48 hours, AS+HNK group intervention with honokiol 32 μmol/L for 48 hours and AS+HNK-PNU group intervention with honokiol 32 μmol/L plus 50 μmol/L PNU-74654 for 48 hours. Real time fluorescence quantitative polymerase chain reaction(RT-PCR) and Western blot were used to detect the mRNA and protein level of Wnt and β-catenin in cells after intervention. Transwell assay was used to detect cell migration. Results Compared with control group, triglyceride, total cholesterol and low-density lipoprotein cholesterol(LDL-C) levels increased in AS group. Blood lipid levels decreased in AS+HNK group and AS+HNK-PNU group compared with AS group. Compared with control group, media cross-sectional area and wall thickness, Wnt and β-catenin protein levels of thoracic aorta increased in AS group. Honokiol reduced media cross-sectional area, wall thickness and Wnt and β-catenin protein levels of thoracic aorta in AS model, which can be partially blocked by PNU-74654(P<0.05). In vitro experiments, the mRNA and protein level of Wnt and β-catenin increased by ox-LDL in HUVEC and HA-VCMS cells(P<0.05). The mRNA and protein level of Wnt and β-catenin in AS+HNK group deceased compared with AS group and AS+HNK-PNU gorup. Compared with control group, the migration of VSMC in AS group increased. The migration of VSMC in AS+HNK group and AS+HNK-PNU group decreased compared with AS group(P<0.05). Conclusions Honokiol decreases Wnt and β-catenin level, suppresses VSMC migration and ameliorates atherosclerosis in AS model. The mechanism of anti-atherosclerosis by honokiol can be mediated in part by Wnt/β-catenin signaling pathway.

     

/

返回文章
返回